Scientists developed a novel approach termed HOPE, which focused on activating the exogenous effector gene CRISPR-Cas13a within cancer cells.
[nan]
NF-κB-Activated Oncogene Inhibition Strategy for Cancer Gene Therapy
Home Newsletters Cell Therapy News NF-κB-Activated Oncogene Inhibition Strategy for Cancer Gene Therapy
